Results 91 to 100 of about 1,425 (166)

[Malnutrition in Inflammatory Bowel Disease]. [PDF]

Rev Med Inst Mex Seguro Soc
Ramos-Mérida Y, Yamamoto-Furusho J, Martínez-Vázquez SE.   +2 more
europepmc   +1 more source

Is (critical) health literacy a key to better psychosomatic functioning in patients with inflammatory bowel disease? Testing a mediation model. [PDF]

Front Psychiatry
Papp-Zipernovszky O, Horvát B, Dávid A, Rafael B, Tóth-Njers S, Strausz D, Gyóllai M, Molnár T, Sallay V, Konkolÿ Thege B, Martos T.   +10 more
europepmc   +1 more source

Ulcerative skin lesions in a child with colitis ulcerosa after colectomy. [PDF]

BMJ Case Rep, 2011
van Zitteren LM, Bovenschen HJ, Tjon A Ten WE.   +2 more
europepmc   +1 more source

[Correction: Position paper of the Society for Paediatric Gastroenterology and Nutrition (GPGE) on the off-label use of biologics and signal inhibitors in children and adolescents with IBD that have already been approved for adults]. [PDF]

Z Gastroenterol
Däbritz J, Classen M, Krohn K, Krahl A, Buderus S, Lainka E, de Laffolie J, Posovszky C.   +7 more
europepmc   +1 more source

Risk factors for Kienböck's disease and need for surgical intervention: a nationwide register study from Finland. [PDF]

J Hand Surg Eur Vol
Wernér K, Anttila T, Viljakka T, Ryhänen J, Hulkkonen S.   +4 more
europepmc   +1 more source

Papel del laboratorio clínico en el estudio de nefrolitiasis y cristaluria por mesalazina. [PDF]

Adv Lab Med
Balbuena AI, Poveda N, López A, Ferri MJ.   +3 more
europepmc   +1 more source

The Impact of H1-H4 Receptor Antagonists on the Levels of Selected Oxidative Stress Markers in Liver and Muscle Tissue in an Animal Model of Colitis. [PDF]

Pharmaceuticals (Basel)
Bogielski B, Michalczyk K, Gębski W, Rozpędek K, Szulińska E, Tempka B, Zorychta A, Chełmecka E, Kaczmar E, Głodek P, John J, Nikiel K, Skrzep-Poloczek B, Jochem J, Kieć-Kononowicz K, Łażewska D, Stygar D.   +16 more
europepmc   +1 more source

Hidradenitis suppurativa in patients with inflammatory bowel disease: a national multicenter study from the GETECCU-ENEIDA Registry. [PDF]

Ther Adv Gastroenterol
Madero-Velázquez L, de Francisco R, Herreros B, Yagüe C, Bujanda L, Calvet X, Ponferrada A, Aguas M, Rodríguez-Moranta F, Marín-Jiménez I, Catalá L, Gargallo-Pueyo C, Huguet J, Mesonero F, Monfort D, Sierra-Ausín M, Igualada L, Ricart-Gomez E, González-Vivo M, García MJ, Camba AH, Elorza A, Zabalza-San Martín L, Ramos L, Martín-Arranz MD, Ruiz-Núñez I, Martínez-Montiel P, Soto P, Roig C, Molina M, Mañosa M, Alba C, Barreiro-de Acosta M, Gisbert JP, Ramírez de la Piscina P, Lorente R, Zabana Y, Botella B, Riestra S, Belen-Galipienso O, Busquets D, Argüelles F, Pascual JC, Zapater P, Domènech E, Gutiérrez A.   +45 more
europepmc   +1 more source

Telemonitoring of Active Inflammatory Bowel Disease Using the App TECCU: Short-Term Results of a Multicenter Trial of GETECCU. [PDF]

J Med Internet Res
Aguas M, Del Hoyo J, Vicente R, Barreiro-de Acosta M, Melcarne L, Hernandez-Camba A, Madero L, Arroyo MT, Sicilia B, Chaparro M, Martin-Arranz MD, Pajares R, Mesonero F, Mañosa M, Martinez P, Chacón S, Tosca J, Marín S, Sanroman L, Calvo M, Monfort D, Saiz E, Zabana Y, Guerra I, Varela P, Baydal V, Faubel R, Corsino P, Porto-Silva S, Brunet E, González M, Gutiérrez A, Nos P.   +32 more
europepmc   +1 more source

[Position paper of the Society for Paediatric Gastroenterology and Nutrition (GPGE) on the off-label use of biologics and signal inhibitors in children and adolescents with IBD that have already been approved for adults]. [PDF]

Z Gastroenterol
Däbritz J, Classen M, Krohn K, Krahl A, Buderus S, Lainka E, de Laffolie J, Posovszky C.   +7 more
europepmc   +1 more source